Connection
Abraham Nussbaum to Treatment Outcome
This is a "connection" page, showing publications Abraham Nussbaum has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.114 |
|
|
|
-
Rylander M, Winston HR, Medlin H, Hull M, Nussbaum A. The association of cannabis use on inpatient psychiatric hospital outcomes. Am J Drug Alcohol Abuse. 2018; 44(1):73-84.
Score: 0.055
-
Nussbaum AM, Stroup TS. Paliperidone palmitate for schizophrenia. Schizophr Bull. 2012 Nov; 38(6):1124-7.
Score: 0.040
-
Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy. 2013 Feb; 33(2):195-209.
Score: 0.010
-
Stroup TS, McEvoy JP, Ring KD, Hamer RH, LaVange LM, Swartz MS, Rosenheck RA, Perkins DO, Nussbaum AM, Lieberman JA. A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). Am J Psychiatry. 2011 Sep; 168(9):947-56.
Score: 0.009